PATENT CLAIM ANALYSIS

Application Number: 16149913
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["560", "124000"]

Abstract:
A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO in an individual by providing a composition comprising a compound set forth in Formula (I):

Claim (Index 11):
The method of  claim 10 , wherein the cardiovascular disease is selected from the group consisting of angina, arrhythmia, atherosclerosis, cardiomyopathy, congestive heart failure, coronary artery disease (CAD), carotid artery disease, endocarditis, coronary thrombosis, myocardial infarction (MI), high blood pressure/hypertension, hypercholesterolemia/hyperlipidemia, mitral valve prolapsed, peripheral artery disease (PAD), and stroke.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 97.0
- Lexical Diversity: 1.17241
- Patent Class: 560.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15366940', '14866398', '15605437', '13915299', '13363661']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7593798416112796
- 35 USC 102 Novelty (BERT): 0.5631412635948007
- Combined Prediction Score: 0.7397559838096317
- Mean Citation Score: 245.85887
- Max Citation Score: 376.33347
- Similarity Product: 225.28762725648164

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test